Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Leukemia, Myeloid, Acute 82Myelodysplastic Syndromes 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 69Lymphoma, Non-Hodgkin 63Hodgkin Disease 62Leukemia 56Multiple Myeloma 52Lymphoma 46Lymphoma, Follicular 44Lymphoma, Mantle-Cell 41Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Lymphoma, Large B-Cell, Diffuse 40Lymphoma, B-Cell, Marginal Zone 39Myeloproliferative Disorders 36Burkitt Lymphoma 35Congenital Abnormalities 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 27Hematologic Neoplasms 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 22Neoplasms, Plasma Cell 22Leukemia, Myeloid, Accelerated Phase 22Anemia, Refractory, with Excess of Blasts 22Graft vs Host Disease 21Primary Myelofibrosis 20Recurrence 19Leukemia, Prolymphocytic 19Dendritic Cell Sarcoma, Interdigitating 18

Interventions

Ipilimumab 106Nivolumab 101pembrolizumab 90aldesleukin 72Cyclophosphamide 46Interleukin-2 45Temozolomide 36Dacarbazine 32trametinib 31dabrafenib 30fludarabine phosphate 29incomplete Freund's adjuvant 27Bevacizumab 26sargramostim 25Vemurafenib 25fludarabine 22binimetinib 21Radiosurgery 21Paclitaxel 20encorafenib 19Carboplatin 19CTLA-4 Antigen 18cobimetinib 16atezolizumab 15Radiotherapy 14Biopsy 14Sorafenib 13MART-1 Antigen 12talimogene laherparepvec 11montanide ISA 51 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Melanoma × Mycophenolic Acid × Clear all
NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

NCT00006233 2011-11-30

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Fred Hutchinson Cancer Center

Phase 2 Completed
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡